GT Biopharma (GTBP: OTCQB) Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer February 15, 2018
GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia February 13, 2018
GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis January 9, 2018
GT Biopharma, Inc. Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis Autoimmune Muscular Disease December 6, 2017
Dr. Jeffrey Miller to Present Data on GT Biopharma Next Generation TriKE (OXS-C3550) at the Upcoming ASH Meeting in Atlanta, Ga November 30, 2017
